Related references
Note: Only part of the references are listed.Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU
Ehsan Sharifipour et al.
BMC INFECTIOUS DISEASES (2020)
Antimicrobial use, drug-resistant infections and COVID-19
Timothy M. Rawson et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020
Stephen Perez et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Brazil: the emerging epicenter of COVID-19 pandemic
Mariane Barros Neiva et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2020)
Molecular epidemiology of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae in different facilities in Southern Brazil
Lavinia N. Arend et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2015)
Combined therapy for multi-drug-resistant Acinetobacter baumannii infection - is there evidence outside the laboratory?
Felipe F. Tuon et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Molecular epidemiology characterization of OXA-23 carbapenemase-producing Acinetobacter baumannii isolated from 8 Brazilian hospitals using repetitive sequence-based PCR
Juliette M. Cieslinski et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Share Paper
